2JB-33026-37371 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-01-14
Registered in v-safe
2021-01-14
Dose 1 — Pfizer-BioNTech
2021-01-14
Survey response — day 0, dose 1
MedDRA: Muscular weakness, Tremor — Feeling: Good · Site: Pain · Fatigue or tiredness

Free text: Shaky & slightly weak in arms & legs

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-15
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · None

Adult check-in
2021-01-17
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities

Adult check-in
2021-01-17
Report sent to call center — days 1–6 daily, dose 1
Be unable to work · Be unable to do your normal daily activities

1 call case(s)
2021-01-18
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-01-19
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Fatigue or tiredness, Nausea · Be unable to do your normal daily activities

Adult check-in
2021-01-21
Survey response — day 7, dose 1
MedDRA: Axillary pain — Feeling: Fair · Headache

Free text: Armpit pain

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-28
Health check-in — day 14, dose 1
Feeling: Fair

Adult check-in
2021-02-04
Dose 2 — Pfizer-BioNTech
2021-02-06
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain, Itching · Fever · Headache, Nausea · Be unable to do your normal daily activities

Adult check-in
2021-02-09
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Fatigue or tiredness

Adult check-in
2021-02-11
Health check-in — day 7, dose 2
Feeling: Good · Headache

Adult check-in
2021-02-18
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-02-25
Survey response — day 21, dose 2
MedDRA: Fatigue, Headache — Feeling: Poor · Be unable to do your normal daily activities

Free text: Fatigue headache

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-04
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-03-18
Survey response — day 42, dose 2
MedDRA: Chest pain — Feeling: Fair · Be unable to do your normal daily activities

Free text: Chest pains

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-05-06
Survey response — 3 months, dose 2
MedDRA: Arthralgia, Dyspnoea, Fatigue — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Extreme fatigue & hair loss, joint pain, vision issues, & shortness of breath/difficulty breathing

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-05-06
Report sent to call center — 3 months, dose 2
Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-06-11
Call 1 — Left Voicemail
2021-08-05
Survey response — 6 months, dose 2
MedDRA: Central serous chorioretinopathy, Malaise, Visual impairment — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit

Free text: Covid symptoms plus vision issues including central serous retinopathy

MedDRA releases: 2021-09,2024-11 · check-in free text available
2021-08-05
Report sent to call center — 6 months, dose 2
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

1 call case(s)
2021-08-09
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-01-14	Pfizer-BioNTech
2	2021-02-04	Pfizer-BioNTech

Call center

Reported	Outcome	VAERS-related outcome
2021-01-17	priority 2/3
2021-05-06	Unsuccessful
2021-08-05	Unsuccessful

Free text

Release 1 — day 0, dose 1

2021-01-14

Systemic reaction (other): Shaky & slightly weak in arms & legs

Release 2 — day 7, dose 1

2021-01-21

Systemic reaction (other): Armpit pain

Release 4 — day 21, dose 2

2021-02-25

Symptoms: Fatigue headache

Release 5 — day 42, dose 2

2021-03-18

Symptoms: Chest pains

Release 8 — 3 months, dose 2

2021-05-06

Symptoms: Extreme fatigue & hair loss, joint pain, vision issues, & shortness of breath/difficulty breathing

Release 9 — 6 months, dose 2

2021-08-05

Symptoms: Covid symptoms plus vision issues including central serous retinopathy

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Arthralgia	✓	✓	✓
SD	Central serous chorioretinopathy	✓	·	✓
SD	Chest pain	✓	✓	✓
SD	Dyspnoea	✓	✓	✓
SD	Fatigue	✓	✓	✓
SD	Headache	✓	✓	✓
SD	Malaise	✓	·	✓
SD	Visual impairment	✓	·	✓
SRO	Axillary pain	✓	✓	✓
SRO	Muscular weakness	✓	✓	✓
SRO	Tremor	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release